Products Affected - Description
Azathioprine injection, lyophilized powder, West-Ward
100 mg vial (NDC 55390-0600-20)
Reason for the Shortage
- West-Ward Pharmaceuticals’ parent company, Hikma Pharmaceuticals, acquired azathioprine injection from Bedford in July 2014.West-Ward is not actively marketing azathioprine injection.
- There are no other manufacturers of azathioprine injection.
- The oral presentations are not affected by this shortage.
No presentations are available.
Estimated Resupply Dates
West-Ward is not actively marketing azathioprine injection.
March 23, January 16, 2015; October 20, August 4, May 1, February 3, 2014; November 1, August 9, June 11, April 17, March 7, January 28, 2013; December 17, October 30, September 10, July 12, June 19, May 4, March 26, February 3, 2012; December 9, November 21, October 27, September 29, August 3, July 1, June 29, May 20, 2011, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins